Review of Self-Reported Data from UK Do-It-Yourself Artificial Pancreas System (DIYAPS) Users to Determine Whether Demographic of Population Affects Use or Outcomes.

Introduction: This study investigates the use of do-it-yourself artificial pancreas systems (DIYAPS) in the UK, and whether self-reported outcomes associated with them are affected by the demographics of the user.

Methods: An online survey was conducted to assess user demographic data and self-reported time-in-range (TIR) outcomes. Statistical analysis was undertaken to review the results and check whether there were major differences in change in TIR across age, gender and duration of diabetes.

Hybrid closed-loop therapy: Where are we in 2021?

Hybrid closed-loop systems are characterized by the coexistence of algorithm-driven automated insulin delivery combined with manual mealtime boluses. Used correctly, these insulin delivery systems offer better glucose control and reduced risk of hypoglycaemia and represent the most advanced form of insulin delivery available for people with type 1 diabetes. The aim of this paper was to compare the currently available commercial hybrid closed-loop systems in the UK: the Medtronic 670G/780G, Tandem t:slim X2 Control IQ and CamAPS FX systems.

Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men.

Background: Obesity increases the risk of many serious illnesses such as coronary heart disease, type 2 diabetes and osteoarthritis. More men than women are overweight or obese in the UK but men are less likely to perceive their weight as a problem and less likely to engage with weight-loss services.

Objective: The aim of this study was to systematically review evidence-based management strategies for treating obesity in men and investigate how to engage men in obesity services by integrating the quantitative, qualitative and health economic evidence base.